NASDAQ:AXSM
$69.80
(
2.51%
)
Friday, 26th May 2023
Axsome Therapeutics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $67.07 | $82.85 | Friday, 26th May 2023 AXSM stock ended at $69.80. This is 2.51% more than the trading day before Thursday, 25th May 2023. During the day the stock fluctuated 4.33% from a day low at $67.68 to a day high of $70.61. |
| 90 days | $53.71 | $82.85 | |
| 52 weeks | $20.63 | $82.85 |
Historical Axsome Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2023-05-26 | $69.85 | $70.61 | $67.68 | $69.80 | 810 322 |
| 2023-05-25 | $68.92 | $69.17 | $67.07 | $68.09 | 868 667 |
| 2023-05-24 | $71.00 | $71.04 | $68.68 | $68.73 | 994 525 |
| 2023-05-23 | $74.83 | $75.06 | $71.64 | $71.82 | 538 939 |
| 2023-05-22 | $75.63 | $76.21 | $73.56 | $74.62 | 618 007 |
| 2023-05-19 | $77.28 | $77.32 | $74.55 | $75.71 | 595 846 |
| 2023-05-18 | $78.51 | $79.04 | $75.90 | $76.87 | 460 603 |
| 2023-05-17 | $77.21 | $79.12 | $75.61 | $78.49 | 446 199 |
| 2023-05-16 | $77.15 | $77.23 | $74.70 | $77.08 | 440 118 |
| 2023-05-15 | $79.37 | $80.31 | $77.05 | $77.77 | 677 197 |
| 2023-05-12 | $78.00 | $80.25 | $77.55 | $79.01 | 516 698 |
| 2023-05-11 | $80.99 | $82.20 | $77.30 | $77.97 | 798 167 |
| 2023-05-10 | $77.06 | $80.94 | $76.50 | $80.22 | 854 663 |
| 2023-05-09 | $77.73 | $81.12 | $76.27 | $76.74 | 1 131 827 |
| 2023-05-08 | $78.00 | $82.85 | $74.05 | $77.73 | 2 764 092 |
| 2023-05-05 | $71.79 | $73.98 | $70.38 | $73.74 | 959 871 |
| 2023-05-04 | $71.87 | $71.87 | $68.84 | $71.15 | 663 764 |
| 2023-05-03 | $71.36 | $72.62 | $70.46 | $71.96 | 526 836 |
| 2023-05-02 | $70.12 | $71.96 | $70.12 | $71.28 | 490 939 |
| 2023-05-01 | $71.69 | $72.94 | $70.25 | $70.77 | 411 245 |
| 2023-04-28 | $71.17 | $71.68 | $69.66 | $71.53 | 381 839 |
| 2023-04-27 | $70.25 | $71.58 | $69.80 | $71.16 | 367 107 |
| 2023-04-26 | $71.00 | $71.67 | $67.50 | $70.11 | 809 013 |
| 2023-04-25 | $73.45 | $74.10 | $70.79 | $71.23 | 500 030 |
| 2023-04-24 | $72.81 | $73.59 | $70.77 | $73.32 | 523 271 |
| 2023-04-21 | $71.64 | $76.35 | $71.64 | $72.92 | 1 073 440 |
| 2023-04-20 | $71.57 | $71.99 | $69.91 | $71.29 | 662 934 |
| 2023-04-19 | $72.85 | $72.85 | $70.99 | $72.15 | 525 840 |
| 2023-04-18 | $70.70 | $72.92 | $69.91 | $72.85 | 917 939 |
| 2023-04-17 | $68.99 | $71.90 | $68.99 | $70.46 | 1 440 460 |
| 2023-04-14 | $64.71 | $68.69 | $64.33 | $68.50 | 1 255 658 |
| 2023-04-13 | $63.95 | $66.47 | $63.66 | $65.05 | 619 193 |
| 2023-04-12 | $61.65 | $64.78 | $61.14 | $63.64 | 1 159 172 |
| 2023-04-11 | $61.30 | $62.56 | $59.98 | $61.03 | 760 052 |
| 2023-04-10 | $59.58 | $61.66 | $56.75 | $61.59 | 817 410 |
| 2023-04-06 | $58.84 | $59.86 | $57.30 | $59.75 | 773 822 |
| 2023-04-05 | $59.58 | $60.31 | $57.47 | $58.41 | 908 459 |
| 2023-04-04 | $62.77 | $62.80 | $59.52 | $59.93 | 851 212 |
| 2023-04-03 | $61.73 | $63.35 | $61.57 | $62.98 | 512 903 |
| 2023-03-31 | $61.31 | $62.61 | $60.37 | $61.68 | 664 648 |
| 2023-03-30 | $62.97 | $63.00 | $58.69 | $60.55 | 1 112 906 |
| 2023-03-29 | $62.50 | $62.89 | $61.01 | $62.44 | 463 374 |
| 2023-03-28 | $64.07 | $64.32 | $60.74 | $61.51 | 727 700 |
| 2023-03-27 | $62.18 | $64.15 | $61.80 | $63.92 | 503 857 |
| 2023-03-24 | $61.40 | $62.58 | $59.74 | $61.96 | 698 914 |
| 2023-03-23 | $63.50 | $65.56 | $61.47 | $62.01 | 747 358 |
| 2023-03-22 | $62.92 | $64.85 | $62.43 | $62.96 | 637 013 |
| 2023-03-21 | $63.58 | $64.63 | $62.75 | $62.88 | 1 029 579 |
| 2023-03-20 | $62.34 | $63.62 | $60.65 | $63.20 | 675 349 |
| 2023-03-17 | $63.27 | $63.66 | $61.45 | $62.74 | 1 049 350 |
About Axsome Therapeutics
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
